GlassScriptPhysician profile
Halee Alleman
NPI 1396378642
$7,251.71
in general payments reported to CMS, 2019-2025
22 companies · $2,664 in 2025
The $2,664 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $147 · 2021: $689 · 2022: $715 · 2023: $1,814 · 2024: $1,223 · 2025: $2,664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,603 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,602.66 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $1,092.59 | 2020-2025 | Acthar |
| Alcon Vision LLC | $853.02 | 2021-2025 | Tryptyr, Total30, Precision 1 |
| Sun Pharmaceutical Industries INC. | $825.93 | 2023-2025 | Cequa |
| Bausch & Lomb Americas INC. | $735.78 | 2023-2025 | Miebo, Xiidra, Envista Envy |
| Allergan, INC. | $568.07 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $501.03 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $393.55 | 2021-2025 | |
| Dompe US, INC. | $369.14 | 2020-2025 | Oxervate |
| Abbvie INC. | $287.61 | 2022-2025 | Alphagan P, Lumigan, Vuity |
| Amgen INC. | $270.44 | 2024-2025 | Tepezza, Uplizna |
| Horizon Therapeutics Plc | $209.34 | 2022-2023 | Tepezza, Uplizna |
| Harrow Eye, LLC | $192.40 | 2024-2025 | Vevye |
| Kala Pharmaceuticals, INC. | $158.61 | 2021-2022 | |
| Oyster Point Pharma, INC. | $147.45 | 2023 | Tyrvaya |
| Lkc Technologies, INC. | $127.34 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $123.76 | 2023 | |
| Aerie Pharmaceuticals, INC. | $92.59 | 2021 | |
| Sight Sciences, INC. | $85.25 | 2025 | Tearcare System |
| Tearlab Corp | $77.90 | 2024 | Scoutpro Osmolarity System |
| Thea Pharma INC. | $76.48 | 2025 | Iyuzeh |
| Rayner Intraocular Lenses Limited | $37.90 | 2025 | Rayone Spheric, Rayone Emv, Rayner Cataract Set 1 |
| Regeneron Healthcare Solutions, INC. | $25.53 | 2023 | Eylea Hd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Halee Alleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.